Soluble HLA class I antigens in chronic hepatitis C: A disease- associated manifestation or molecules modulating immunoresponsiveness?

Immunopharmacology and Immunotoxicology

Volumn 21, Issue 4, 1999, Pages 727-738

  Antonaci, Salvatore ^a,b   Jirillo, Emilio ^a   Schiraldi, Oronzo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b Immunologia e Malattie Infettive   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FAS LIGAND; HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; DISEASE ACTIVITY; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; IMMUNOTHERAPY; LIVER INJURY; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 0032751013     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979909007138     Document Type: Review

References (50)

1. Calne, R.Y., White, H.J., Yoffa, D.E., Maggin, R.R., Binns, R.M., Samuel, J.R., Molina, V.P., Observations of orthotopic liver transplantation in the pig, Br. Med. J., 2:478, 1967.
2. Calne, R.Y., Sells, R.A., Pena, J.R., Davis, D.R., Millard, P.R., Herbertson, P.M., Binns, R.M., Davies, D.A., Induction of immunological tolerance by porcine liver allografts, Nature, 223:472, 1969.
3. Zimmermann, F.A., Butcher, G.W., Davies, H.S., Brons, G., Kamada, N., Turel, O., Techniques for orthotopic liver transplantation in the rat and some studies of the immunological responses to fully allogeneic liver grafts, Transplant. Proc., 11:571, 1979.
4. Van Rood, J.J., Van Leeuwan, A., Van Santen, M.C.T., Anti HLA-A2 inhibitor in normal human sera, Nature, 226:366, 1970.
5. Mathew, J.M., Shenoy, S., Phelan, D., Lowell, J., Howard, T., Mohanakumar, T., Biochemical and immunological evaluation of donor specific soluble HLA in the circulation of liver transplant recipients, Transplantation, 62:217, 1996.
6. Zavazava, N., Böttcher, H., Mueller-Ruchholtz, W.M., Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients, Tissue Antigens, 42:20, 1993.
7. DeVito-Haynes, L.D., Jankowska-Gan, E., Sollinger, H.W., Knechtle, S.J., Burlingham, W.J., Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific soluble HLA class I, Hum. Immunol., 40:191, 1994.
8. Puppo, F., Scudeletti, M., Indiveri, F., Ferrone, S., Serum HLA class I antigens: markers and modulators of an immune response?, Immunol. today, 16:124, 1995.
9. Emerson, S., Murphy, D., Cone, R., Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex, J. Exp. Med., 152:783, 1980.
10. Emerson, S., Cone, R., Absorption of shed I-Ak and H-2Kk antigens by lymphoid cells, Transplantation, 33:36, 1982.
11. Zavazava, N., Soluble HLA class I molecules: biological significance and clinical implications, Mol. Med. Today, 4:116, 1998.
12. Allison, J.P., Pellegrino, M.A., Ferrone, S., Callahan, G.N., Reisfeld, R.A., Biologic and chemical characterization of HLA antigens in human serum, J. Immunol., 118:1004, 1977.
13. McDonald, J.C., Gelder, F.B., Aultman, D.F., Landreneau, M.D., McMillan, R.W., Singh, I., Sorrells, D., Liou, W.H., HLA in human serum: quantitation of class I by enzyme immunoassay, Transplantation, 53:445, 1992.
14. Inostroza, J., Ferrada, J., Navarrete, C., Sorensen, R.U., Soluble histocompatibility class I antigens and beta 2-microglobulin in pregnant females and cord blood samples, Hum. Immunol., 54:63, 1997.
15. Alvarez-Cermeno, J., Echevarria, J.M., Villar, L.M., Lazaro, I., Bootello, A., Gonzalez-Porque, P., Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis, J. Neurol. Neurosurg. Psychiatry, 52:1194, 1989.
16. Ferreira, A., Villar, M.L., Alvarez-Cermeno, J.C., Revilla, Y., Garcia Rodriguez, M.C., Fontan, G., Gonzalez-Porque, P., Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients, Clin. Chim. Acta, 174:207, 1988.
17. Puppo, F., Orlandini, A., Ruzzenenti, R., Comuzio, S., Salamito, A., Farinelli, A., Stagnaro, R., Indiveri, F., HLA class I soluble antigen serum levels in HIV-positive subjects: correlation with cellular and serological parameters, Cancer Detect. Prevent., 14:321, 1990.
18. Puppo, F., Brenci, S., Lanza, L., Bosco, O., Imro, M.A., Scudeletti, M., Indiveri, F., Ferrone, S., Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression, Hum. Immunol., 40:259, 1994.
19. Filaci, G., Contini, P., Brenci, S., Gazzolla, P., Lanza, L., Scudeletti, M., Indiveri, F., Mancardi, G.L., Puppo, F., Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients, Hum. Immunol., 54:54, 1997.
20. Wolf, R.E., Adamashvili, I.M., Gelder, F.B., Hall, V.C., Fraser, P.A., McDonald, J.C., Soluble HLA-I in rheumatic diseases, Hum. Immunol., 59:644, 1998.
21. Puppo, F., Brenci, S., Montinaro, E., Lanza, L., Contini, P., Scudeletti, M., Indiveri, F., Inhibition of alloreactive cytotoxic T cell activity by HIV-positive sera: potential role of circulating soluble HLA class I molecules, AIDS Res. Hum. Retrovir., 10:1061, 1994.
22. Ghio, M., Contini, P., Mazzei, C., Brenci, S., Barberis, G., Filaci, G., Indiveri, F., Puppo, F., Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions, Blood, 93:1770, 1999.
23. Fiore, G., Angarano, I., Caccetta, L., Serrone, M., Jirillo, E., Schiraldi, O., Antonaci, S., In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C, Eur. J. Gastroenterol. Hepatol., 9:491, 1997.
24. Fiore, G., Piazzolla, G., Angarano, I., Galetta, V., Caccetta, L., Jirillo, E., Schiraldi, O., Antonaci, S., Intrahepatic cytotoxic cell infiltrates in chronic hepatitis B and C: a comparative immunohistochemical study, Med. Sci. Res., 25:755, 1997.
25. Khakoo, S.I., Soni, P.N., Savage, K., Brown, D., Dhillon, A.P., Poulter, L.W., Dusheiko, G.M., Lymphocyte and macrophage phenotypes in chronic hepatitis C infection, Am. J. Pathol., 150:963, 1997.
26. Fiore, G., Galetta, V., Piazzolla, G., Angarano, I., Jirillo, E., Schiraldi, O., Antonaci, S., CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C, Microbios, 92:73, 1997.
27. Onji, M., Kikuchi, T., Kumon, I., Masumoto, T., Nadano, S., Kajno, K., Horiike, N., Ohta, Y., Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C, Hepatogastroenterology, 39:340, 1992.
28. Volpes, R., Van Der Oord, J.J., Desmet, V.J., Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation, Hepatology, 13:826, 1991.
29. Mosnier, J.F., Scoazec, J.Y., Marcellin, P., Degott, C., Benhamou, J.P., Feldmann, G., Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C, Gastroenterology, 107:1457, 1994.
30. Mochizuki, K., Hayashi, N., Katayama, K., Hiramitsu, N., Kanto, T., Mita, E., Tatsumi, T., Kuzushita, N., Kasahara, A., Fusamoto, H., Yokochi, T., Kamada, T., B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C, Hepatology, 25:713, 1997.
31. Hiramatsu, N., Hayashi, N., Katayama, K., Mochizuchi, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., Kamada, T., Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C, Hepatology, 19:1354, 1994.
32. Antonaci, S., Schiraldi, O., Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A review, Immunopharmacol. Immunotoxicol., 20:455, 1998.
33. Fiore, G., Piazzolla, G., Galetta, V., Caccetta, L., Schiraldi, O., Antonaci, S., Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activity, Microbios, 97:29, 1999.
34. Liaw, Y.F., Lee, C.S., Tsai, S.L., Liaw, B.W., Chen, T.C., Sheen, I.S., Chu, C.M., T cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection, Hepatology, 22:1368, 1995.
35. Piazzolla, G., Giannelli, L., Antonelli, G., Tortorella, C., Jirillo, E., Schiraldi, O., Antonaci, S., Effects of interferon-α treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C, Immunopharmacol. Immunotoxicol., 18:529, 1996.
36. Kuzushita, N., Hayashi, N., Moribe, T., Katayama, K., Kanto, T., Nakatani, S., Kaneshige, T., Tatsumi, T., Ito, A., Mochizuki, K., Sasaki, Y., Kasahara, A., Hori, M., Influence of HLA haplotypes on the clinical course of individuals infected with hepatitis C virus, Hepatology, 27:240, 1998.
37. Olcese, L., Lang, P., Vely, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K.L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J.C., Vivier, E., Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases, J. Immunol., 156:4531, 1996.
38. Large, M.K., Kittlesen, D.J., Hahn, Y.S., Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence, J. Immunol., 162:931, 1999.
39. Tsai, S.L., Chen, Y.M., Chen, M.H., Huang, C.Y., Sheen, I.S., Yeh, C.T., Huang, J.H., Kuo, G.C., Liaw, Y.F., Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity, Gastroenterology, 115:954, 1998.
40. Puppo, F., Picciotto, A., Brenci, S., Varagona, G., Scudeletti, M., Ghio, M., Balestra, V., Celle, G., Indiveri, F., Behaviour of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?, J. Clin. Immunol., 15:179, 1995.
41. Hagihara, M., Shimura, T., Takebe, K., Munkhbat, B., Yamamoto, K., Hosoi, K., Kagawa, T., Watanabe, N., Matsuzaki, S., Tsuji, K., The changes of serum soluble HLA-class I and CD8 concentrations during interferon treatment of chronic hepatitis C patients, Int. Hepatol. Commun., 6:316, 1997.
42. Freni, M.A., Ajello, A., Spadaro, A., Fava, A., Calapristi, I., Marafioti, T., Alessi, N., Resta, M.L., Ferrau, O., Class I HLA antigens hepatic display and Beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon, Hepatogastroenterology, 44:1295, 1997.
43. Singer, D.S., Maguire, J.E., Regulation of the expression of class I MHC genes, Crit. Rev. Immunol., 10:235, 1990.
44. Hagihara, M., Shimura, T., Takebe, K., Munkhbat, B., Hosoi, K., Kagawa, T., Watanabe, N., Matsuzaki, S., Yamamoto, K., Sato, K., Tsuji, K., Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders, J. Gastroenterol., 32:338, 1997.
45. Piazzolla, G., Tortorella, C., Fiore, G., Serrone, M., Caccetta, L., Jirillo, E., Schiraldi, O., Antonaci, S., Immunoresponsiveness in chronic hepatitis C patients: correlation between tissue and serum findings, Immunopharmacol. Immunotoxicol., 20:337, 1998.
46. Quiroga, J.A., Martin, J., Pardo, M., Carreno, V., Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α, Dig. Dis. Sci., 39:2485, 1994.
47. Kaplanski, G., Farnarier, C., Payan, M.J., Bongrand, P., Durand, J.M., Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis, Dig. Dis. Sci., 42:2277, 1997.
48. Zavazava, N., Kronke, M., Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes, Nat. Med., 2:1005, 1996.
49. Nagata, S., Golstein, P., The Fas death factor, Science, 267:1449, 1995.
50. Tanaka, M., Suda, T., Takahashi, T., Nagata, S., Expression of the functional soluble form of human Fas ligand in activated lymphocytes, EMBO J., 14:1129, 1995.